Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/02/20245:00AMPR Newswire (Canada)/R E P R I S E -- Avis aux médias - En pleine négociation, les intervenantes en petite enfance de la FIPEQ-CSQ participeront à l'activité de mobilisation de Ma place au travail/
06/02/20245:00AMPR Newswire (Canada)/R E P E A T -- Media Advisory: Infrastructure Announcement in Halifax/
06/02/20245:00AMPR Newswire (Canada)/R E P R I S E -- Avis aux médias : Annonce en matière d'infrastructure à Halifax/
06/02/20244:00AMPR Newswire (Canada)AVIS DE FERMETURE DE RUES : aujourd'hui, dimanche 2 juin, à l'occasion du Tour de l'Île de Montréal
06/02/20241:08AMPR Newswire (Canada)Ontario Lottery and Gaming Corporation - EVENING LOTTERY WINNING NUMBERS - June 1, 2024
06/01/202410:56PMPR Newswire (US)Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC
06/01/202410:30PMPR Newswire (Canada)'A Red Cross for Journalism': Committee to Protect Journalists awarded Canadian Association of Journalists' 2024 Charles Bury Award
06/01/202410:30PMPR Newswire (Canada)« Une Croix-Rouge pour le journalisme » : Le Comité de protection des journalistes reçoit le prix Charles Bury 2024 de l'Association canadienne des journalistes
06/01/202410:30PMPR Newswire (Canada)L'Association canadienne des journalistes honore l'excellence du journalisme canadien de l'année écoulée lors de son gala annuel de remise de prix
06/01/202410:30PMPR Newswire (Canada)Canadian Association of Journalists celebrates excellence in Canadian journalism from the past year at annual awards gala
06/01/20247:25PMPR Newswire (US)Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
06/01/20247:17PMPR Newswire (US)CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
06/01/20246:13PMPR Newswire (US)GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at the Oral Presentation of 2024 ASCO A
06/01/20245:09PMPR Newswire (US)LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
06/01/20245:06PMPR Newswire (US)NAISMA Announces PlayCleanGo® Awareness Week 2024: Real People, Real Stories
06/01/20244:52PMPR Newswire (US)Sun Bum Makes SPF Waves in Miami with its Largest Ever Beach Hangout for Skin Cancer Awareness Month
06/01/20244:18PMPR Newswire (Canada)Avis aux médias - Itinéraire de la vice-première ministre pour le dimanche 2 juin 2024
06/01/20244:10PMPR Newswire (Canada)Media Advisory - Deputy Prime Minister's itinerary for Sunday, June 2, 2024
06/01/20244:00PMPR Newswire (Canada)Media Advisory - Prime Minister's itinerary for Sunday, June 2, 2024
06/01/20244:00PMPR Newswire (Canada)Avis aux médias - Itinéraire du premier ministre pour le dimanche 2 juin 2024
06/01/20243:30PMPR Newswire (US)Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation
06/01/20242:40PMPR Newswire (US)BIOHACKING CONFERENCE ANNOUNCES STEMREGENⓇ WILL RETURN AS TITLE SPONSOR FOR 2025
06/01/20242:00PMPR Newswire (US)Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting
06/01/20241:08PMPR Newswire (US)Thrive with GBA | The Bay to Bay Dialogue held to deepen mutual understanding between China and US
06/01/20241:00PMPR Newswire (Canada)Le gouvernement du Québec dévoile les résultats de la consultation sur la mobilité dans les régions de la Capitale-Nationale et de la Chaudière-Appalaches
06/01/202412:55PMPR Newswire (US)Back Nine Greens Announce a New Dealer: North Texas Luxury Lawns
06/01/202412:45PMPR Newswire (US)Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract UpdatesNASDAQ:KPTIKaryopharm Therapeutics Inc
06/01/202412:42PMPR Newswire (Canada)Thrive with GBA | The Bay to Bay Dialogue held to deepen mutual understanding between China and US
06/01/202412:42PMPR Newswire (US)Thrive with GBA | The Bay to Bay Dialogue held to deepen mutual understanding between China and US
06/01/202412:10PMPR Newswire (US)Taseko Announces that Operations at its Gibraltar Mine have been SuspendedLSE:TKOTaseko Mines Limited

Your Recent History

Delayed Upgrade Clock